{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:42:24Z","timestamp":1777495344778,"version":"3.51.4"},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Fecal incontinence (FI) affects up to 8% of adults and substantially impairs quality of life. Surgical options carry higher risk and cost, and evidence for minimally invasive alternatives, such as anal inserts, is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether a novel anal insert achieves a clinically meaningful reduction in FI severity compared with usual care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This multicenter, open-label, randomized clinical superiority trial was conducted from May 26, 2021, to August 1, 2024, with 8 weeks of treatment and 4 weeks of follow-up at 2 outpatient hospital clinics in the Netherlands. Participants were individuals aged 16 to 90 years with FI (Rome IV criteria) with at least 1 FI episode during a 14-day run-in period. Data were analyzed from August 2 to December 20, 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>A single-use anal insert compared with usual care alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was proportion of participants achieving a reduction of at least 3 points in the St Mark\u2019s incontinence score from baseline to 8 weeks. Secondary outcomes included FI-specific quality of life, anxiety, depression, adverse events, and weekly FI episodes (post hoc outcome).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 73 participants were screened and 72 were randomized (60 [83.3%] female; mean [SD] age, 67.3 [9.8] years]), with 35 participants receiving the insert and 37 receiving usual care. There was no significant difference in reduction in St Mark\u2019s score (9 participants [25.7%] in the insert group vs 7 participants [18.9%] in the control group; relative risk, 1.36 [95% CI, 0.57 to 3.25]). Coping (mean between-group difference, 0.19 [95% CI, 0.03 to 0.35]) and depression (mean between-group difference, 0.15 [95% CI, 0.01 to 0.30]) domains of the quality-of-life assessment improved more with the insert group, whereas lifestyle and embarrassment domains of the quality-of-life assessment, anxiety, and overall depression showed no between-group differences. The insert reduced FI episodes (estimated mean difference, \u22123.09 [95% CI, \u22124.39 to \u22121.75] episodes per week) and increased the proportion achieving more than 50% reduction in FI episodes. No serious adverse events occurred; device-related adverse events were common but mild.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this randomized clinical trial, the primary outcome of achieving a reduction of at least 3 points in St Mark\u2019s incontinence score was not met; however, the anal insert improved selected FI-specific quality-of-life domains. These findings suggest that the device may provide a minimally invasive option for selected patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT04657588\">NCT04657588<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.9208","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:00:59Z","timestamp":1777388459000},"page":"e269208","source":"Crossref","is-referenced-by-count":0,"title":["Controlling Fecal Incontinence With a Novel Anal Device"],"prefix":"10.1001","volume":"9","author":[{"given":"Sad\u00e9 L.","family":"Assmann","sequence":"first","affiliation":[{"name":"Department of Surgery and Colorectal Surgery, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Department of Gastroenterology-Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjorn","family":"Winkens","sequence":"additional","affiliation":[{"name":"Care and Public Health Research Institute, Maastricht University, the Netherlands"},{"name":"Department of Methodology and Statistics, Maastricht University, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bours","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology-Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Essers","sequence":"additional","affiliation":[{"name":"Care and Public Health Research Institute, Maastricht University, the Netherlands"},{"name":"Department of Clinical Epidemiology and Medical Technology Assessment, Care and Public Health, Maastricht University Medical Center, Maastricht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tze","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology-Hepatology, Rijnstate Hospital, Arnhem, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zlatan","family":"Mujagi\u0107","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology-Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie O.","family":"Breukink","sequence":"additional","affiliation":[{"name":"Department of Surgery and Colorectal Surgery, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands"},{"name":"Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Keszthelyi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology-Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"6","key":"zoi260285r1","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1053\/j.gastro.2016.02.009","article-title":"Anorectal disorders.","volume":"150","author":"Rao","year":"2016","journal-title":"Gastroenterology"},{"issue":"11","key":"zoi260285r2","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1007\/s11136-024-03756-3","article-title":"Living with faecal incontinence: a qualitative investigation of patient experiences and preferred outcomes through semi-structured interviews.","volume":"33","author":"Assmann","year":"2024","journal-title":"Qual Life Res"},{"issue":"4","key":"zoi260285r3","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cgh.2023.09.004","article-title":"Global prevalence of fecal incontinence in community-dwelling adults: a systematic review and meta-analysis.","volume":"22","author":"Mack","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"zoi260285r4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ueg2.12213","article-title":"Guideline for the diagnosis and treatment of faecal incontinence\u2014a UEG\/ESCP\/ESNM\/ESPCG collaboration.","volume":"10","author":"Assmann","year":"2022","journal-title":"United European Gastroenterol J"},{"issue":"5","key":"zoi260285r5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1463-1318.2001.00257.x","article-title":"Anal plug for faecal incontinence.","volume":"3","author":"Norton","year":"2001","journal-title":"Colorectal Dis"},{"issue":"8","key":"zoi260285r6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/BF02048363","article-title":"Clinical assessment of the anal continence plug.","volume":"36","author":"Christiansen","year":"1993","journal-title":"Dis Colon Rectum"},{"issue":"8762","key":"zoi260285r7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0140-6736(91)90428-R","article-title":"The anal continence plug: a disposable device for patients with anorectal incontinence.","volume":"338","author":"Mortensen","year":"1991","journal-title":"Lancet"},{"issue":"9","key":"zoi260285r8","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/DCR.0000000000000427","article-title":"Evaluation of an anal insert device for the conservative management of fecal incontinence.","volume":"58","author":"Lukacz","year":"2015","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"zoi260285r9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/codi.14587","article-title":"The Renew anal insert for passive faecal incontinence: a retrospective audit of our use of a novel device.","volume":"21","author":"Leo","year":"2019","journal-title":"Colorectal Dis"},{"issue":"4","key":"zoi260285r10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s10151-007-0371-9","article-title":"The Protect device in the treatment of severe fecal incontinence: preliminary results of a multicenter trial.","volume":"11","author":"Giamundo","year":"2007","journal-title":"Tech Coloproctol"},{"issue":"9","key":"zoi260285r11","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1111\/j.1572-0241.2002.05987.x","article-title":"The procon incontinence device: a new nonsurgical approach to preventing episodes of fecal incontinence.","volume":"97","author":"Giamundo","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"zoi260285r12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/gut.44.1.77","article-title":"Prospective comparison of faecal incontinence grading systems.","volume":"44","author":"Vaizey","year":"1999","journal-title":"Gut"},{"issue":"3","key":"zoi260285r13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00192-012-1886-9","article-title":"Responsiveness and interpretability of incontinence severity scores and FIQL in patients with fecal incontinence: a secondary analysis from a randomized controlled trial.","volume":"24","author":"Bols","year":"2013","journal-title":"Int Urogynecol J"},{"issue":"8","key":"zoi260285r14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S2468-1253(25)00013-5","article-title":"Faecal incontinence core outcome set: an international Delphi consensus exercise among patients, health-care professionals, and researchers.","volume":"10","author":"Assmann","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10004","key":"zoi260285r15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/S0140-6736(15)60314-2","article-title":"Percutaneous tibial nerve stimulation versus sham electrical stimulation for the treatment of faecal incontinence in adults (CONFIDeNT): a double-blind, multicentre, pragmatic, parallel-group, randomised controlled trial.","volume":"386","author":"Knowles","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"zoi260285r16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrgastro.2015.117","article-title":"Placebo effects and their determinants in gastrointestinal disorders.","volume":"12","author":"Elsenbruch","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2848232\/assmann_2026_oi_260285_1776795222.35608.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:01:00Z","timestamp":1777388460000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2848232"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.9208","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}